Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population

作     者：Josh Bilson Christopher D.Byrne 

作者机构：School of Human Development and HealthFaculty of MedicineUniversity of SouthamptonSouthamptonUK National Institute for Health Research Southampton Biomedical Research CentreUniversity of Southampton and University Hospital Southampton National Health Service Foundation TrustSouthamptonUK 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2023年第12卷第6期

页      面：949-952页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：supported in part by the Southampton NIHR Biomedical Research Centre UK (NIHR 203319) 

主　　题：Fatty liver disease(FLD) non-alcoholic fatty liver disease(NAFLD) metabolic dysfunction steatotic liver disease(MASLD) metabolic dysfunction-associated fatty liver disease(MAFLD) mortality age elderly older population 

摘      要：Accumulating evidence in recent years has reinforced the notion that non-alcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease/metabolic dysfunction steatotic liver disease(NAFLD/MAFLD/MASLD)is a multisystem disease that increases the risk of all-cause and disease-specific mortality(1,2).